QUOTE AND NEWS
Benzinga  10 hrs ago  Comment 
In a report published Tuesday, Deutsche Bank analyst Greg Poole reiterated a Hold rating on Perrigo (NYSE: PRGO), and raised the price target from $117.00 to $120.00. In the report, Deutsche Bank noted, “Perrigo announced today that it has...
StreetInsider.com  Jun 17  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Perrigo+%28PRGO%29+to+Acquire+Ophthalmic+Assets+from+Fera+Pharma/8421520.html for the full story.
TheStreet.com  Jun 7  Comment 
NEW YORK (TheStreet) -- TheStreet's Debra Borchardt met with Perrigo CEO Joe Papa to talk about some of the new products and changes the company is making. Perrigo is celebrating its 125th anniversary this year, and on Friday it moved from the...
Market Intelligence Center  Jun 6  Comment 
Perrigo (NASDAQ: PRGO) closed Wednesday's trading session at $113.14. In the past year, the stock has hit a 52-week low of $98.79 and 52-week high of $121.33. Perrigo (PRGO) stock has been showing support around $110.16 and resistance in the...
StreetInsider.com  May 31  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Netflix+%28NFLX%29+Will+Be+Added+to+NASDAQ-100%2C+Replacing+Perrigo+%28PRGO%29/8381059.html for the full story.
StreetInsider.com  May 29  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Perrigo+%28PRGO%29+Files+ANDA+for+Generic+Axiron+Topical+Solution/8374627.html for the full story.
StreetInsider.com  May 29  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Perrigo+%28PRGO%29+Approved+for+Generic+Sanctura+XR/8374459.html for the full story.
Market Intelligence Center  May 17  Comment 
Perrigo (NASDAQ: PRGO) closed Thursday's trading session at $119.81. In the past year, the stock has hit a 52-week low of $98.25 and 52-week high of $121.33. Perrigo (PRGO) stock has been showing support around $118.93 and resistance in the...
TheStreet.com  May 10  Comment 
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK (TheStreet) -- Here are some of the hot stocks Jim Cramer talked about on Thursday's "Mad Money" on CNBC: PRGO data by...




 

Perrigo Company is a global health-care supplier and the world's largest manufacturer of over-the-counter pharmaceuticals for the store brand market. The company develops, distributes, and manufactures over-the-counter and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients, and consumer products.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki